Vitamin D3 for Life

Live Enlightened

Research libraryVitamin D3 For Life
Study design and methods

Secondary relevance to vitamin D This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

This paper mainly addresses another topic and also reports a vitamin D analysis, result or scientific synthesis.

Why this paper is included

Supporting source evidence:

The main variables associated with a reduced or increased AOR for fatigue were employment status, education status, type of MS, DMD use, smoking status, alcohol use, physical activity, vitamin D supplementation, meditation, social support, BMI, and diet (Table 4).

Source: Results. View original paper

Relevance classification does not establish study quality, causation or editorial approval.

Study design Cross-sectional study.

Cross-sectional study

Examines a population at a particular point in time.

Meta-analysis unclear · Blinding unclear / not reported · Human research reported

How this paper was classified

Automatic source-based classification; awaiting editorial verification. This is not a quality score.

International Differences in Multiple Sclerosis Health Outcomes and Associated Factors in a Cross-sectional Survey

Source: Article title.

Participants were recruited via MS society websites and newsletters, MS blogs, MS forums, Facebook pages, and Twitter accounts specific for PwMS over 15 weeks in 2012.

Source: Methods.

View supporting evidence in the original paper

What the study types mean
Systematic review
Uses explicit methods to identify, assess and summarise research on a defined question.
Scoping review
Maps the extent and characteristics of research on a topic.
Narrative review
Discusses existing research; systematic-review methods have not been established by this classification.
Review / evidence synthesis
Reviews existing research; the exact review methods need further assessment.
Randomised controlled trial
Assigns participants or groups to comparison interventions by chance.
Non-randomised intervention study
Examines an intervention without random allocation.
Cohort study
Examines exposures and outcomes over time within a defined group.
Case-control study
Compares people with an outcome against people without it, examining exposures.
Cross-sectional study
Examines a population at a particular point in time.
Observational study
Observes exposures and outcomes without assigning the exposure; the subtype is not established here.
Case report
Describes an individual case.
Case series
Describes a group of individual cases.
Secondary analysis
Analyses existing study data; this paper is not automatically another independent trial.
Laboratory study
Investigates biological processes in a laboratory setting.
Qualitative study
Examines experiences or meanings using qualitative methods.
Genetic instrumental-variable study
Uses genetic variation as an instrument to investigate relationships; this is not a randomised treatment trial.
Study protocol
Describes planned methods and is not evidence that the planned study has reported results.
Multiple reported designs
More than one design is explicitly reported; examine the supporting methods.
Study design awaiting verification
The available source does not establish a sufficiently clear study design.

Meta-analysis combines numerical results from studies. Blinding describes who was unaware of treatment allocation. Neither is a separate quality grade. Study design, vitamin D relevance and document format are independent filters.

Abstracts

International Differences in Multiple Sclerosis Health Outcomes and Associated Factors in a Cross-sectional Survey

Cross-sectional study · Frontiers in Neurology · 2017

Original publication title

International Differences in Multiple Sclerosis Health Outcomes and Associated Factors in a Cross-sectional Survey

Grace D. Reilly; Awng Shar Mahkawnghta; Pia L. Jelinek; Alysha M. De Livera; Tracey J. Weiland; Chelsea R. Brown; Keryn L. Taylor; Sandra L. Neate; George A. Jelinek; Claudia H. Marck

Copyright © 2017 Reilly, Mahkawnghta, Jelinek, De Livera, Weiland, Brown, Taylor, Neate, Jelinek and Marck.

Original publication · Publisher record · CC BY 4.0

Source wording retained. Formatting, section navigation and display-title punctuation adapted for this research record.

At a glance

What does the authors’ abstract report?

Multiple sclerosis (MS) is a major cause of disability and poor quality of life (QOL). Previous studies have shown differences in MS health outcomes between countries. This study aimed to examine the associations between international regions and health outcomes in people with MS. Self-reported data were taken from the Health Outcomes and Lifestyle In a Sample of people with Multiple Sclerosis online survey collected in 2012. The 2,401 participants from 37 countries were categorized into three regions: Australasia, Europe, and North America.

Differences were observed between regions in disability, physical and mental health QOL, fatigue, and depression, but most of these disappeared after adjusting for sociodemographic, disease, and lifestyle factors in multivariable regression models. However, adjusted odds for disability were higher in Europe [odds ratio (OR): 2.17, 95% confidence interval (CI): 1.28 to 3.67] and North America (OR: 1.79, 95% CI: 1.28 to 2.51) compared to Australasia. There may be other unmeasured factors that vary between regions, including differences in access and quality of healthcare services, determining disability in MS.

When assessing differences in MS health outcomes, lifestyle factors and medication use should be taken into consideration.

Authors’ abstract

Multiple sclerosis (MS) is a major cause of disability and poor quality of life (QOL). Previous studies have shown differences in MS health outcomes between countries. This study aimed to examine the associations between international regions and health outcomes in people with MS. Self-reported data were taken from the Health Outcomes and Lifestyle In a Sample of people with Multiple Sclerosis online survey collected in 2012. The 2,401 participants from 37 countries were categorized into three regions: Australasia, Europe, and North America.

Differences were observed between regions in disability, physical and mental health QOL, fatigue, and depression, but most of these disappeared after adjusting for sociodemographic, disease, and lifestyle factors in multivariable regression models. However, adjusted odds for disability were higher in Europe [odds ratio (OR): 2.17, 95% confidence interval (CI): 1.28 to 3.67] and North America (OR: 1.79, 95% CI: 1.28 to 2.51) compared to Australasia. There may be other unmeasured factors that vary between regions, including differences in access and quality of healthcare services, determining disability in MS.

When assessing differences in MS health outcomes, lifestyle factors and medication use should be taken into consideration.

Publication and source details

Original title: International Differences in Multiple Sclerosis Health Outcomes and Associated Factors in a Cross-sectional Survey

Grace D. Reilly; Awng Shar Mahkawnghta; Pia L. Jelinek; Alysha M. De Livera; Tracey J. Weiland; Chelsea R. Brown; Keryn L. Taylor; Sandra L. Neate; George A. Jelinek; Claudia H. Marck

Frontiers in Neurology · 2017

Edited by: Björn Tackenberg, Philipps University of Marburg, Germany

Reviewed by: Benedikt Frank, Essen University Hospital, Germany; Markus Kraemer, Alfried Krupp von Bohlen und Halbach Foundation, Germany

*Correspondence: Claudia H. Marck, claudia.marck@unimelb.edu.au

†These authors have contributed equally as first authors.

Specialty section: This article was submitted to Multiple Sclerosis and Neuroimmunology, a section of the journal Frontiers in Neurology

Copyright © 2017 Reilly, Mahkawnghta, Jelinek, De Livera, Weiland, Brown, Taylor, Neate, Jelinek and Marck.2017Reilly, Mahkawnghta, Jelinek, De Livera, Weiland, Brown, Taylor, Neate, Jelinek and Marckhttps://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.National Health and Medical Research Council10.13039/5011000009251120014

Repository JATS snapshot; version as supplied

Source retrieved: 2026-11-12T19:39:45.370938+00:00

DOI: 10.3389/fneur.2017.00229 · PMC5450014